Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Income-focused investors in Vistin Pharma ASA (OB: VISTN) have a narrow window remaining to qualify for the Norwegian pharmaceutical company's next dividend payment. The ex-dividend date falls on May 22, meaning any investor who has not settled a…
Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX
Commerzbank Aktiengesellschaft FI purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 25,417 shares of the biopharmaceutical…
Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX
Qsemble Capital Management LP acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 74,416…
HRF alleges unchecked industrial effluent discharge in Anakapalli district
The Human Rights Forum (HRF) has alleged large-scale discharge of untreated and inadequately treated industrial effluents into water bodies in the Atchutapuram-Rambilli industrial corridor of Anakapalli district, and demanded immediate intervention…
Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth (NASDAQ:SBRA)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
The Great Capital Migration: What 5 Months of Closed Reg CF Campaigns Reveal About the Future of Impact Crowdfunding in 2026
You can advertise in Superpowers for Good. Click to learn more about our affordable options. Over the past five months, the Regulation Impact Crowdfunding ecosystem has demonstrated remarkable resilience and evolution. As we analyze the data from…
Tech lawyers return to the fold
Several years ago, law firms reported a trend of lawyers leaving for other companies, taking on in-house legal positions within those companies, and even non-legal roles. The phenomenon was particularly common in tech companies but was also seen in…
Millennium Capital Advisors LLC Purchases New Shares in AbbVie Inc. $ABBV
Millennium Capital Advisors LLC purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 11,875 shares…
AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC
WealthPlan Investment Management LLC trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 21.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…
AbbVie (NYSE:ABBV) Rating Lowered to Buy at Wall Street Zen
AbbVie (NYSE:ABBV - Get Free Report) was downgraded by research analysts at Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a report released on Sunday. The Most Important Part of These 3 Big Pharma Earnings Reports Wasn't the Beat…
Soltis Investment Advisors LLC Acquires 12,096 Shares of AbbVie Inc. $ABBV
Soltis Investment Advisors LLC lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 55.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,077 shares of the…
San Francisco startups are pushing a hot peptide summer
By Zara Stone Tech Culture Reporter A few years ago, entrepreneur Julius Ritter was a peptide skeptic. Then he started injecting the compounds regularly into his stomach and backside. Ritter, a blond, brown-eyed 24-year-old with a Clavicular jaw…
The Goldman Sachs Group, Inc. $GS Position Increased by May Hill Capital LLC
May Hill Capital LLC raised its holdings in shares of The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 101.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,402 shares of…
L & S Advisors Inc Has $8.01 Million Stake in AbbVie Inc. $ABBV
L & S Advisors Inc lowered its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 18.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,064 shares of the company's…
Barr E S & Co. Sells 2,597 Shares of The Goldman Sachs Group, Inc. $GS
Barr E S & Co. lowered its holdings in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 146,426…
Receive a Daily briefing on Pharma Industry News
Get Started